Table 1 Baseline clinical and angiographic characteristics

Age (years)

66.8 ± 11.2

64.9 ± 12.4

Male

231 (66.4%)

234 (67.6%)

Body mass index (Kg/m²)

24.5 ± 4.1

24.5 ± 4.1

Hypertension

238 (68.4%)

249 (72.0%)

Diabetes mellitus

138 (39.7%)

124 (35.8%)

Dyslipidemia

123 (35.9%)

120 (35.4%)

Smoking

90 (25.9%)

110 (31.8%)

Family history of coronary artery disease

20 (5.7%)

33 (9.5%)

Chronic kidney disease

16 (4.6%)

17 (4.9%)

Prior stroke

37 (10.6%)

37 (10.7%)

Prior myocardial infarction

32 (9.2%)

23 (6.6%)

Prior percutaneous coronary intervention

46 (13.2%)

43 (12.4%)

Clinical presentation

 Stable angina

19 (5.5%)

22 (6.4%)

 Unstable angina

153 (44.0%)

155 (44.8%)

 NSTEMI

110 (31.6%)

107 (30.9%)

 STEMI

60 (17.2%)

56 (16.2%)

 Silent myocardial ischemia

6 (1.7%)

6 (1.7%)

Left ventricular ejection fraction (%)

54.5 ± 12.1

55.6 ± 11.3

Total cholesterol (mg/dl)

165.6 ± 46.3

164.2 ± 43.2

Triglyceride (mg/dl)

141.0 ± 86.0

154.1 ± 133.4

HDL cholesterol (mg/dl)

41.6 ± 10.5

41.3 ± 9.9

LDL cholesterol (mg/dl)

101.0 ± 34.1

99.0 ± 31.8

High-sensitivity C-reactive protein (mg/l)

8.4 ± 23.9

10.0 ± 28.0

eGFR (ml/min/1.73m²)

69.6 ± 26.4

73.8 ± 30.8

NT-proBNP (pg/ml)

1384.0 ± 4585.9

1919.1 ± 6243.0

Culprit lesion

 Left anterior descending

171 (51.5%)

165 (49.8%)

 Left circumflex

62 (18.7%)

54 (16.3%)

 Right coronary artery

83 (25.0%)

95 (28.7%)

 Left main

15 (4.5%)

17 (5.1%)

Extent of coronary artery disease

 1-vessel disease

164 (49.4%)

146 (44.1%)

 2-vessel disease

100 (30.1%)

119 (36.0%)

 3-vessel disease

68 (20.5%)

66 (19.9%)

Multivessel disease

103 (29.6%)

112 (32.4%)

Number of total stents

1.6 ± 1.0

1.7 ± 1.2

Mean diameter of stents

3.10 ± 0.43

3.11 ± 0.41

Total length of stents

42.2 ± 28.8

46.8 ± 35.4